Source link : https://www.newshealth.biz/health-news/nhs-will-not-fund-donanemab-for-alzheimers/
The National Institute for Health and Care Excellence (NICE) has recommended that donanemab is not approved for use on the NHS on the day that the Medicines and Healthcare products Regulatory Agency (MHRA) approved the drug as a new treatment for adults in the early stages of the condition who have one or no copies […]
Author : News Health
Publish date : 2024-10-23 15:58:02
Copyright for syndicated content belongs to the linked Source.